Market closedNon-fractional
OptiNose/OPTN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About OptiNose
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
Ticker
OPTN
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Yardley, United States
Employees
132
Website
www.optinose.com
OptiNose Metrics
BasicAdvanced
$156M
Market cap
-
P/E ratio
-$0.27
EPS
-0.10
Beta
-
Dividend rate
Price and volume
Market cap
$156M
Beta
-0.1
Financial strength
Current ratio
1.579
Quick ratio
1.579
Long term debt to equity
-132.759
Total debt to equity
-133.49
Interest coverage (TTM)
-0.67%
Management effectiveness
Return on assets (TTM)
-10.36%
Return on equity (TTM)
35.49%
Valuation
Price to revenue (TTM)
1.638
Price to book
-1.23
Price to tangible book (TTM)
-1.23
Price to free cash flow (TTM)
-3.739
Growth
Revenue change (TTM)
0.90%
Earnings per share change (TTM)
-62.78%
3-year revenue growth (CAGR)
11.07%
3-year earnings per share growth (CAGR)
-47.94%
What the Analysts think about OptiNose
Analyst Ratings
Majority rating from 4 analysts.
OptiNose Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15M
-25.25%
Net income
-$14M
41.41%
Profit margin
-94.59%
89.18%
OptiNose Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.02
-$0.08
-$0.09
-$0.12
-
Expected
-$0.11
-$0.09
-$0.09
-$0.11
-$0.08
Surprise
-118.43%
-15.19%
-4.59%
11.63%
-
OptiNose News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OptiNose stock?
OptiNose (OPTN) has a market cap of $156M as of July 27, 2024.
What is the P/E ratio for OptiNose stock?
The price to earnings (P/E) ratio for OptiNose (OPTN) stock is 0 as of July 27, 2024.
Does OptiNose stock pay dividends?
No, OptiNose (OPTN) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next OptiNose dividend payment date?
OptiNose (OPTN) stock does not pay dividends to its shareholders.
What is the beta indicator for OptiNose?
OptiNose (OPTN) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.
Buy or sell OptiNose stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.